Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes



Status:Not yet recruiting
Conditions:Obesity Weight Loss, Endocrine, Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - 99
Updated:2/20/2019
Start Date:April 2019
End Date:April 2021
Contact:Associate Professor
Email:sunhkim@stanford.edu
Phone:(650) 723-8284

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Real-Time Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes

The primary objective of this study is to determine whether intermittent use of continuous
glucose monitor will facilitate weight loss in individuals who are overweight/obese with
prediabetes.

Continuous glucose monitoring (CGM) has revolutionized the treatment of patients on intensive
insulin therapy and its utility can also be harnessed to help individuals with prediabetes
make healthful lifestyle changes. Successful weight loss requires adherence to lower
calories, regular exercise, and self-monitoring. This proposal will test the hypothesis that
intermittent CGM will facilitate all of these components for successful weight loss by
functioning as a continuous self-monitor and guiding healthful food choices and physical
activity.

Inclusion Criteria:

- Overweight/obese (BMI 25-40 kg/m2)

- Prediabetes (fasting glucose 100-125 mg/dL and/or HbA1c 5.7-6.4%)

Exclusion Criteria:

- On glucose-lowering medications (e.g., metformin)

- On weight-loss medications
We found this trial at
1
site
Stanford
Stanford, California 94304
Phone: 650-723-8284
?
mi
from
Stanford, CA
Click here to add this to my saved trials